Deceased organ donor screening for HIV, hepatitis B, and hepatitis C viruses: A survey of organ procurement organization practices

American Journal of Transplantation

Volumn 13, Issue 8, 2013, Pages 2186-2190

  Theodoropoulos, N ^a,b   Jaramillo, A ^c   Ladner, D P ^b   Ison, M G ^b  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c Gift of Hope Organ and Tissue Donor Network   (United States)

Author keywords

Deceased organ donor; hepatitis B; hepatitis C; HIV; nucleic acid testing; organ procurement organization; screening; survey

Indexed keywords

DECEASED ORGAN DONOR; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; NUCLEIC ACID TESTING; ORGAN DONOR; PRIORITY JOURNAL; REVIEW; SCREENING; SCREENING TEST; SEROLOGY; UNITED STATES;

DECEASED ORGAN DONOR; HEPATITIS B; HEPATITIS C; HIV; NUCLEIC ACID TESTING; ORGAN PROCUREMENT ORGANIZATION; SCREENING; SURVEY;

CADAVER; DISEASE TRANSMISSION, INFECTIOUS; DNA, VIRAL; DONOR SELECTION; GENETIC TESTING; HEALTH CARE SURVEYS; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HIV; HIV INFECTIONS; HUMANS; ORGAN TRANSPLANTATION; SEROLOGIC TESTS; TISSUE AND ORGAN HARVESTING; TISSUE DONORS;

EID: 84881373971     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12260     Document Type: Review

References (11)

1. OPTN Policy 2.0 Minimum procurement standards for an organ procurement organization (OPO)May 18, 2011. Available from: http://www.unos.org/ PoliciesandBylaws2/policies/pdfs/policy-2.pdf
2. Ison MG, Llata E, Conover CS, et al. Transmission of human immunodeficiency virus and hepatitis C virus from an organ donor to four transplant recipients. Am J Transplant 2011; 11: 1218-1225.
3. Kucirka LM, Sarathy H, Govindan P, et al. Risk of window period hepatitis-C infection in high infectious risk donors: Systematic review and meta-analysis. Am J Transplant 2011; 11: 1188-1200.
4. Kucirka LM, Sarathy H, Govindan P, et al. Risk of window period HIV infection in high infectious risk donors: Systematic review and meta-analysis. Am J Transplant 2011; 11: 1176-1187.
5. Kleinman SH, Lelie N, Busch MP., Infectivity of human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion. Transfusion 2009; 49: 2454-2489.
6. Fiebig EW, Wright DJ, Rawal BD, et al. Dynamics of HIV viremia, antibody seroconversion in plasma donors: Implications for diagnosis, staging of primary HIV infection. AIDS 2003; 17: 1871-1879.
7. Orlowski J, Alexander C, Ison M, Rosendale J, Chabalewski F., Nucleic acid testing (NAT) for HIV, HBV, and HCV: current practices of 58 US Organ Procurement Organizations (OPOs). [abstract]. Am J Transplant. 2009; 9 (Suppl. s2): 197.
8. Kucirka LM, Alexander C, Namuyinga R, Hanrahan C, Montgomery RA, Segev DL., Viral nucleic acid testing (NAT) and OPO-level disposition of high-risk donor organs. Am J Transplant 2009; 9: 620-628.
9. Humar A, Morris M, Blumberg E, et al. Nucleic acid testing (NAT) of organ donors: is the 'best' test the right test? A consensus conference report. Am J Transplant 2010; 10: 889-899.
10. Public Health Service Guideline for Reducing Transmission of Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV) Through Solid Organ Transplantation 2011 [October 1, 2012]. Available from: http://www.federalregister.gov/articles/2011/09/21/2011-2418 9/public-health-service-guideline-for-reducing-transmission-of-human- immunodeficiency-virus-hiv
11. Kucirka LM, Namuyinga R, Hanrahan C, Montgomery RA, Segev DL., Formal policies and special informed consent are associated with higher provider utilization of CDC high-risk donor organs. Am J Transplant 2009; 9: 629-635.